Unblocking Clinical Inertia: The CMI Era in oHCM Care
About this episode
This episode focuses on improving the diagnosis and management of obstructive hypertrophic cardiomyopathy (oHCM) through a CME-accredited broadcast replay.
CME credits: 0.75 Valid until: 16-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/unblocking-clinical-inertia-the-cmi-era-in-ohcm-care/56382/ Did you miss our symposium at ESC HF 2026? It’s not too late! This CME-accredited broadcast replay focuses on improving the diagnosis and management of obstructive hypertrophic cardiomyopathy (oHCM). Learn how to distinguish oHCM from heart failure and how cardiac myosin inhibitors can optimize patient outcomes. Join us and gain valuable tips on applying these insights in practice. For more information please visit the Heart Failure Congress 2026 website . =
People in this episode
Host: ReachMD
Mentioned in this episode
Products: cardiac myosin inhibitors
Books & works: Heart Failure Congress 2026
Places: oHCM, heart failure
More episodes of ReachMD CME
- No Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
- Closing the Gaps: Global Implementation of Lipid Guidelines
- Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
- Chairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
- Chairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
- Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Explore listener stats, chart rankings, contacts and more on the ReachMD CME podcast page.